Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats

Impaired Ca 2+ handling in resistance arteries from genetically obese Zucker rats: Role of the PI3K, ERK1/2 and PKC signaling pathways

(2018) Ana Sánchez et al.   BIOCHEMICAL PHARMACOLOGY

AT2 receptors in cardiovascular and renal diseases

(2017) Elena Kaschina et al.   PHARMACOLOGICAL RESEARCH

The miR-30 family: Versatile players in breast cancer

(2017) Su-Jin Yang et al.   TUMOR BIOLOGY

Angiotensin Type-2 (AT-2)-Receptor activation reduces renal fibrosis in cyclosporine nephropathy: Evidence for blood-pressure independent effect.

(2016) G. Castoldi et al.   BIOSCIENCE REPORTS

Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis

(2016) Giovanna Castoldi et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

miR-106a promotes cardiac hypertrophy by targeting mitofusin 2

(2016) Xiaoxiang Guan et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets

(2015) Mitsuo Kato et al.   Annals of the New York Academy of Sciences

Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice

(2015) Dong Zheng et al.   DIABETOLOGIA

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

(2015) Ludovit Paulis et al.   DRUGS

Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway

(2015) Wen-fang Li et al.   TUMOR BIOLOGY

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus

(2014) Daniel Lorber   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma

(2013) W. Wang et al.   EJSO

Activation of Angiotensin Type 2 Receptors Partially Ameliorates Streptozotocin-Induced Diabetes in Male Rats by Islet Protection

(2013) Chunhong Shao et al.   ENDOCRINOLOGY

Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates

(2013) F. V. Karginov et al.   GENES & DEVELOPMENT

Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart

(2013) Dilyara Lauer et al.   HYPERTENSION

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats

(2013) Quaisar Ali et al.   KIDNEY INTERNATIONAL

miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy

(2013) Xuesong Yin et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Angiotensin AT2 receptor agonist stimulates high stretch induced- ANP secretion via PI3K/NO/sGC/PKG/pathway

(2013) Shan Gao et al.   PEPTIDES

MiR-30-Regulated Autophagy Mediates Angiotensin II-Induced Myocardial Hypertrophy

(2013) Wei Pan et al.   PLoS One

Diabetes: a 21st century challenge

(2013) Paul Z Zimmet et al.   Lancet Diabetes & Endocrinology

Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats

(2012) Michaël Shum et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The use of animal models in diabetes research

(2012) Aileen JF King   BRITISH JOURNAL OF PHARMACOLOGY

Update on the Angiotensin AT2 Receptor

(2012) Claudia A. McCarthy et al.   CURRENT HYPERTENSION REPORTS

Direct Angiotensin II Type 2 Receptor Stimulation in N ω -Nitro- l -Arginine-Methyl Ester–Induced Hypertension

(2012) Ludovit Paulis et al.   HYPERTENSION

Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ Activation

(2012) Kousei Ohshima et al.   PLoS One

Globalization of Diabetes: The role of diet, lifestyle, and genes

(2011) F. B. Hu   DIABETES CARE

Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats

(2011) Asia Rehman et al.   HYPERTENSION

MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension

(2011) Giovanna Castoldi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Gene silencing by microRNAs: contributions of translational repression and mRNA decay

(2011) Eric Huntzinger et al.   NATURE REVIEWS GENETICS

Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB

(2010) Franziska Rompe et al.   HYPERTENSION

Mammalian microRNAs predominantly act to decrease target mRNA levels

(2010) Huili Guo et al.   NATURE

Cardiac regulation by phosphoinositide 3-kinases and PTEN

(2009) G. Y. Oudit et al.   CARDIOVASCULAR RESEARCH

Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential

(2009) Thomas Unger et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Angiotensin II Type 2 Receptor Stimulation

(2008) Elena Kaschina et al.   CIRCULATION

miR-133 and miR-30 Regulate Connective Tissue Growth Factor

(2008) Rudy F. Duisters et al.   CIRCULATION RESEARCH